Patent · US Active

Modified gene silencing

US11708577B2 · kind B2 · utility

0Cited by

76References

18Claims

0Family size

Assignee

Monsanto Technology LLC · US

Inventors

Joanne J. Fillatti · Davis, US
Jean C. Goley · Chesterfield, US
Gregory R. Heck · Crystal Lake Park, US
Tichafa R. I. Munyikwa · Ballwin, US
Ty T. Vaughn · Clayton, US
Toni Voelker · Davis, US

Key dates

Filing date	Dec 3, 2019
Grant date	Jul 25, 2023
Priority date	—
Expiry date	Jun 5, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N15/8247
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

This invention relates to methods of controlling gene expression or gene suppression in eukaryotic cells. One aspect of this invention includes modifying the degree of silencing of a target gene by use of a modified suppression element. Another aspect includes providing a eukaryotic cell having a desired phenotype resulting from transcription in the eukaryotic cell of a modified suppression element. Also provided are transgenic eukaryotic cells, transgenic plant cells, plants, and seeds containing modified suppression elements, and useful derivatives of such transgenic plant cells, plants, or seeds, such as food or feed products.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.